Pharmacokinetics of ondansetron in patients receiving cisplatin therapy.
Parr
M D
MD
Department of Pharmacy, University Hospital of Arkansas, Little Rock 72205.
McIntyre
W J
WJ
Henderson
L M
LM
MacDonald
J S
JS
Chandler
M H
MH
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D017294:Ondansetron / Q000493:pharmacokinetics*; D010865:Pilot Projects; D011446:Prospective Studies; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy
D017294:Ondansetron; D002945:Cisplatin